Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 2,665-2,676 of 6,115
Drug study icon
TerminatedEUCTR 2004-002482-20

A Pilot Study to Test the Effect of Treating Depression Associated with Rueumatoid Arthritis (RA) using Venlaflaxine

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

Depression, AnxietyDrugA study involving a medication or substance.
Countries
United Kingdom
Sponsor
Newcastle upon Tyne Hospitals NHS Trust
Condition
Depression, Anxiety
Drug study icon
CompletedEUCTR 2009-018064-95

Amyloid imaging in late life depression

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Belgium
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Belgium
Sponsor
University of Leuven
Condition
Depression
Drug study icon
CompletedEUCTR 2005-005597-67

An eight-week, double-blind placebo controlled, multicenter study evaluating the efficacy, safety, tolerability of a fixed dose of SR58611A (350 mg q12) in elderly patients with Major Depressive Di...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Finland
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Finland, Slovakia
Sponsor
sanofi-aventis recherche & développement
Condition
Depression
Drug study icon
CompletedEUCTR 2006-001618-34

An eight-week, randomized, double-blind, two parallel groups, study to assess clinical response of Duloxetine 60 mg and 120 mg per day in patients hospitalized for severe depression

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In France
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
France, Italy
Sponsor
BOEHRINGER ING.
Condition
Depression
Drug study icon
CompletedEUCTR 2009-015165-31

Antiglucocorticoid augmentation of antiDepressants in Depression: a double-blind, randomised, placebo-controlled, parallel-group trial

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
United Kingdom
Sponsor
Northumberland, Tyne and Wear NHS Foundation Trust
Condition
Depression
Drug study icon
CompletedEUCTR 2018-001539-39

Clinical and neurobiological predictors of response to ketamine: towards personalized treatment of depression

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Czech Republic
Why is this study shown?

This study is directly about Depression.

Depression, SchizophreniaDrug
Countries
Czechia
Sponsor
Národní ústav duševního zdraví
Condition
Depression, Schizophrenia
Drug study icon
TerminatedEUCTR 2013-004444-31

Effects and consequences for mother and child from treatment for depression A prospective randomized, placebo- controlled, trial with internet-based cognitive behavior therapy and sertraline or...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Sweden
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Sweden
Sponsor
Condition
Depression
Drug study icon
CompletedEUCTR 2017-000990-35

EFFECTS OF ANTIDEPRESSANT TREATMENT WITH AGOMELATINE ON PATIENTS AFFECTED BY DEPRESSION AND EPILEPSY. A DOUBLE BLIND RANDOMIZED STUDY WITH ACTIVE CONTROL (ESCITALOPRAM) WITH PARALLEL GROUPS.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Italy
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Italy
Sponsor
DIP. MEDICINA DEI SISTEMI UNIVERSITà DEGLI STUDI DI ROMA TOR VERGATA
Condition
Depression
Drug study icon
CompletedEUCTR 2013-002226-23

Efficacy of Pain Treatment on Depression in Patients with Dementia. A Randomized Clinical Trial of Efficacy

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Norway
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Norway
Sponsor
University of Bergen, Department of Global Public Health and Primary Care
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.